Skip to main content

Table 5 Health economics data of all patients enrolled

From: The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study

Health economics data
(10,000 RMB)
PCG(N = 68)
M (IQR)
CG (N = 41)
M (IQR)
P
Medicine 2.51 (1.79–3.27) 2.89 (2.29–4.30) 0.002*
Examination 0.05 (0.03–0.09) 0.06 (0.05–0.08) 0.051
Laboratory test 0.83 (0.68–1.06) 1.00 (0.76–1.18) 0.078
Treatment 7.99 (6.59–9.66) 9.00 (7.59–11.09) 0.024*
Surgery 0.46 (0.45–0.47) 0.47 (0.40–0.47) 0.527
Anesthesia 0.20 (0.18–0.23) 0.22 (0.19–0.23) 0.131
Consumables 3.94 (3.55–4.50) 4.45 (3.45–5.45) 0.140
Others 0.26 (0.21–0.34) 0.47 (0.36–0.54) 0.000*
Total costs 9.23 (7.82–10.97) 10.42 (8.99–12.57) 0.006*
  1. PCG Pre-COVID-19 group, CG COVID-19 group, M Median, IQR Inter-quartile range
  2. * P < 0.05, statistically different